Citation Impact
Citing Papers
Increased Prevalence of Sleep-Disordered Breathing in Adults
2013 Standout
Prospective Study of Obstructive Sleep Apnea and Incident Coronary Heart Disease and Heart Failure
2010 Standout
Biomedically-relevant metal organic framework-hydrogel composites
2023 StandoutNobel
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Antibiotic Management of Lung Infections in Cystic Fibrosis. I. The Microbiome, Methicillin-Resistant Staphylococcus aureus , Gram-Negative Bacteria, and Multiple Infections
2014
Engineering precision nanoparticles for drug delivery
2020 Standout
Targeting microbial biofilms: current and prospective therapeutic strategies
2017 Standout
Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: Formulation, characterisation and functionalisation with dornase alfa (DNase)
2014
Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study
2012
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Goodpasture's syndrome: A clinical update
2014
Liposomes as delivery systems for antibiotics
2009
Childhood thyroid cancer in England and Wales
1995
Cystic fibrosis
2016 Standout
Cystic Fibrosis Therapeutics
2013
Managing Cystic Fibrosis
2011
Pulmonary delivery of tobramycin-loaded nanostructured lipid carriers for Pseudomonas aeruginosa infections associated with cystic fibrosis
2015
Exercise Standards for Testing and Training
2013 Standout
Evolution and clinical translation of drug delivery nanomaterials
2017
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
Emerging Treatments in Cystic Fibrosis
2009
Delivery technologies for cancer immunotherapy
2019 Standout
Electrolyte abnormalities in cystic fibrosis: systematic review of the literature
2013
Sleep-Disordered Breathing and Mortality: A Prospective Cohort Study
2009 Standout
Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections
2014
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
Antimicrobial activity of metals: mechanisms, molecular targets and applications
2013 Standout
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
2015
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Cystic Fibrosis Pulmonary Guidelines
2013
Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity
2010
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships
2008
Cystic fibrosis microbiology: Advances in antimicrobial therapy
2015
ERS statement: interventional bronchoscopy in children
2017
Obstructive Sleep Apnea–Hypopnea and Incident Stroke
2010 Standout
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Lipid and polymer nanoparticles for drug delivery to bacterial biofilms
2014
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
2018
The antimicrobial activity of nanoparticles: present situation and prospects for the future
2017 Standout
Antibiotic and Anti-Inflammatory Therapies for Cystic Fibrosis
2013
Essential oils: From extraction to encapsulation
2015 Standout
Treatment of lung infection in patients with cystic fibrosis: Current and future strategies
2012
Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilms
2014
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease
2016
Tannic Acid with Antiviral and Antibacterial Activity as A Promising Component of Biomaterials—A Minireview
2020 Standout
Nanomedicine review: clinical developments in liposomal applications
2019
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Physiology of sweat gland function: The roles of sweating and sweat composition in human health
2019 Standout
Sleep Apnea and Cardiovascular Disease
2008
Sleep Apnea and Cardiovascular Disease
2008
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
2008
Oxadiazoles in Medicinal Chemistry
2011 Standout
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Chernobyl-Related Thyroid Cancer in Children of Belarus: A Case-Control Study
1998 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
2018 Standout
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
2021 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials
2016
Analysis of nanoparticle delivery to tumours
2016 Standout
The oral microbiota: dynamic communities and host interactions
2018 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Congenital Malformations
1953 Standout
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
2016
Progress in Nanomedicine: Approved and Investigational Nanodrugs.
2017
Clinical Translation of Nanomedicine
2015
Works of Predrag Minić being referenced
Spectrum of Cystic Fibrosis Mutations in Serbia and Montenegro and Strategy for Prenatal Diagnosis
2004
Thyroid/Cervical Teratomas in Children: Immunohistochemical Studies for Specific Thyroid Epithelial Cell Markers
1994
Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: The EVOLVE trial
2010
Phase II studies of nebulised Arikace in CF patients withPseudomonas aeruginosainfection
2013
Pulmonary renal syndrome in a child with coexistence of anti-neutrophil cytoplasmic antibodies and anti-glomerular basement membrane disease: case report and literature review
2013
A randomized placebo-controlled study of nebulized liposomal amikacin (Arikace™) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection
2008
Pulmonary involvement in siblings with Gaucher disease type III
2011
Atypical presentation of cystic fibrosis: Obese adolescent with hypertension and pseudo-Bartter’s syndrome
2012
[Cor pulmonale caused by hypertrophic adenoid glands and tonsils: indications for tonsillectomy and adenoidectomy in a 2-year-old child].
2000
Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection
2009